BROOKLYN CHAMPION: Open Payments
NPI 1871264515 · OXFORD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,101 in 122 payments from 25 companies in 2025. Trend: 2023 $301 · 2024 $3,090 · 2025 $2,101
Food & beverage: $2,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $487 |
| Novo Nordisk Inc | 10 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $168 |
| Amgen Inc. | 10 | $151 |
| PFIZER INC. | 11 | $142 |
| Otsuka America Pharmaceutical, Inc. | 6 | $139 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| UCB, Inc. | 5 | $84 |
| Janssen Biotech, Inc. | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
Products named: REXULTI, CAPLYTA, RINVOQ, SKYRIZI, VRAYLAR, XELJANZ, Ozempic, SAPHNELO.
Industry payments across AL — which companies pay providers there.
